Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Change in Taxes (2019 - 2020)

Pliant Therapeutics (PLRX) has disclosed Change in Taxes for 2 consecutive years, with -$178000.0 as the latest value for Q2 2020.

  • On a quarterly basis, Change in Taxes changed N/A to -$178000.0 in Q2 2020 year-over-year; TTM through Mar 2021 was -$178000.0, a N/A change, with the full-year FY2020 number at -$250000.0, down 49.7% from a year prior.
  • Change in Taxes was -$178000.0 for Q2 2020 at Pliant Therapeutics, down from -$72000.0 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $62000.0 in Q3 2019 to a low of -$187000.0 in Q4 2019.